SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-062635
Filing Date
2014-10-09
Accepted
2014-10-09 16:05:39
Documents
1
Period of Report
2014-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4158
  Complete submission text file 0001209191-14-062635.txt   5653
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address 6042 CORNERSTONE CT. WEST, SUITE B SAN DIEGO CA 92121
Business Address
Miao Zhenwei (Reporting) CIK: 0001605519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 141150235